tiprankstipranks
Xtacy Therapeutics Resolves Filing Delay
Company Announcements

Xtacy Therapeutics Resolves Filing Delay

Xtacy Therapeutics Corp. (TSE:XTCY) has released an update.

Stay Ahead of the Market:

Xtacy Therapeutics Corp. has completed the filing of its annual financial statements for the fiscal year ending September 30, 2023, and related management discussions and certifications, now available on SEDAR+ and the CSE website. The company is working to resolve a voluntary management cease trade order by fulfilling its obligations for the upcoming Q1 Interim Financial statements. Xtacy Therapeutics, a company aiding high growth firms in wellness consumer products, reassures that there have been no significant business changes apart from the recent financial disclosures.

For further insights into TSE:XTCY stock, check out TipRanks’ Stock Analysis page.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App